Vindesine-Epirubicin versus Vindesine-Mitoxantrone in Metastatic Breast Cancer

Hubert Hausmaninger,M. Lehnert,G. Steger,Paul Sevelda,G. Michlmayr,W. Hehenwarter,Michael A. Fridrik,H. Samonigg,L. Schiller,D. Manfreda,R. Haidinger,R. Kienzer,A. Neiss

Vindesine-Epirubicin versus Vindesine-Mitoxantrone in Metastatic Breast Cancer

1989

Hubert Hausmaninger
M. Lehnert
G. Steger
Paul Sevelda
G. Michlmayr
W. Hehenwarter
Michael A. Fridrik
H. Samonigg
L. Schiller
D. Manfreda
R. Haidinger
R. Kienzer
A. Neiss

The present study was designed to assess the toxicity and efficacy of two chemotherapy protocols in patients with metastatic breast cancer. Starting in December 1985, 230 patients were randomized to r

Keywords:

Breast cancer
Vindesine
CA15-3
Cancer
General surgery
Mitoxantrone
Epirubicin
Chemotherapy
Metastatic breast cancer
Medicine
Oncology
combination chemotherapy
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations